|Table of Contents|

Research progress of exosomal miRNA in head and neck cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 10
Page:
1923-1928
Research Field:
Publishing date:

Info

Title:
Research progress of exosomal miRNA in head and neck cancer
Author(s):
WANG Yue; TIAN Linli; LIU Ming
Department of Otorhinolaryngology,Head and Neck Surgery,the Second Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 154000,China.
Keywords:
head and neck cancer; exosomes; exosomal miRNA
PACS:
R739.91
DOI:
10.3969/j.issn.1672-4992.2024.10.029
Abstract:
Head and neck cancer is the sixth highest incidence of malignant tumor,including laryngeal cancer,oral cancer,nasopharyngeal carcinoma,thyroid cancer and so on.Many organs are involved,with poor prognosis,high mortality and morbidity.Exosomes are nanoscale vesicular bodies containing a variety of bioactive substances such as RNA and proteins,which can mediate intercellular signal transduction.The miRNA contained in the exosome is called exosomal miRNA.Due to the protection of exosomes vesicle membrane,its stability is better than that of free miRNAs.In recent years,more and more studies have begun to pay attention to the role of exosomal miRNA in the pathogenesis,early clinical diagnosis and monitoring prognosis of head and neck cancer.This article reviews the latest research progress of exosomal miRNA in head and neck cancer.

References:

［1］ GUPTA B,JOHNSON NW,KUMAR N.Global epidemiology of head and neck cancers:a continuing challenge［J］.Oncology,2016,91(1):13-23.
［2］ SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023［J］.CA Cancer J Clin,2023,73(1):17-48.
［3］ KAI K,DITTMAR RL,SEN S.Secretory microRNAs as biomarkers of cancer［J］.Semin Cell Dev Biol,2018,78:22-36.
［4］ KASINSKI AL,SLACK FJ.Epigenetics and genetics.MicroRNAs en route to the clinic:progress in validating and targeting microRNAs for cancer therapy［J］.Nat Rev Cancer,2011,11(12):849-864.
［5］ PASKEH M,ENTEZARI M,MIRZAEI S,et al.Emerging role of exosomes in cancer progression and tumor microenvironment remodeling［J］.J Hematol Oncol,2022,15(1):83.
［6］ KALLURI R,LEBLEU VS.The biology,function,and biomedical applications of exosomes［J］.Science,2020,367(6478):u6977.
［7］ NAM GH,CHOI Y,KIM GB,et al.Emerging prospects of exosomes for cancer treatment:from conventional therapy toimmunotherapy［J］.Adv Mater,2020,32(51):e2002440.
［8］ HO P,CLARK IM,LE LTT.MicroRNA-based diagnosis and therapy［J］.Int J Mol Sci,2022,23(13):7167.
［9］ GOODALL GJ,WICKRAMASINGHE VO.RNA in cancer［J］.Nature Reviews Cancer,2020,21:22-36.
［10］ BARTEL DP.Metazoan microRNAs［J］.Cell,2018,173(1):20-51.
［11］ WEI JX,LV LH,WAN YL,et al.Vps4A functions as a tumor suppressor by regulating the secretion and uptake ofexosomal microRNAs in human hepatoma cells［J］.Hepatology,2015,61(4):1284-1294.
［12］ DEJIMA H,IINUMA H,KANAOKA R,et al.Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence ofnon-small cell lung cancer［J］.Oncol Lett,2017,13(3):1256-1263.
［13］ BAO L,YOU B,SHI S,et al.Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomesmediates angiogenesis by repressing a novel target gene TSGA10［J］.Oncogene,2018,37(21):2873-2889.
［14］ WANG J,JIANG Q,FALETI OD,et al.Exosomal delivery of antagomiRs targeting viral and cellular microRNAs synergistically inhibits cancer angiogenesis［J］.Mol Ther Nucleic Acids,2020,22:153-165.
［15］ ZHONG Q,NIE Q,WU R,et al.Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt/β-catenin signaling pathway［J］.Cell Cycle,2023,22(13):1544-1562.
［16］ XIE L,ZHANG K,YOU B,et al.Hypoxic nasopharyngeal carcinoma-derived exosomal miR-455 increases vascular permeability by targeting ZO-1 to promote metastasis［J］.Mol Carcinog,2023,62(6):803-819.
［17］ WANG H,WANG L,ZHOU X,et al.OSCC exosomes regulate miR-210-3p targeting EFNA3 to promote oral cancer angiogenesis through the PI3K/AKT pathway［J］.Biomed Res Int,2020,2020:2125656.
［18］ WU F,LI F,LIN X,et al.Exosomes increased angiogenesis in papillary thyroid cancer microenvironment［J］.Endocr Relat Cancer,2019,26(5):525-538.
［19］ CAPIK O,GUMUS R,KARATAS OF.Hypoxia-induced tumor exosomes promote angiogenesis through miR-1825/TSC2/mTORaxis in oral squamous cell carcinoma［J］.Head Neck,2023,45(9):2259-2273.
［20］ YE SB,LI ZL,LUO DH,et al.Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma［J］.Oncotarget,2014,5(14):5439-5452.
［21］ YE SB,ZHANG H,CAI TT,et al.Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as apotential prognostic biomarker for nasopharyngeal carcinoma［J］.J Pathol,2016,240(3):329-340.
［22］ JI ZZ,CHAN MK,CHAN AS,et al.Tumour-associated macrophages:versatile players in the tumour microenvironment［J］.Front Cell Dev Biol,2023,11:1261749.
［23］ CAI J,QIAO B,GAO N,et al.Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophagepolarization mediated by exosome-enclosed miR-29a-3p［J］.Am J Physiol Cell Physiol,2019,316(5):C731-C740.
［24］ QIAO L,DONG C,JIA W,et al.Exosomal miR-655-3p inhibits growth,and invasion and macrophage M2 polarization through targeting CXCR4 in papillary thyroid carcinoma［J］.Acta Biochim Pol,2022,69(4):773-779.
［25］ CAMUZARD O,SANTUCCI-DARMANIN S,CARLE GF,et al.Autophagy in the crosstalk between tumor and microenvironment［J］.Cancer Lett,2020,490:143-153.
［26］ LI YY,TAO YW,GAO S,et al.Cancer-associated fibroblasts contribute to oral cancer cells proliferation andmetastasis via exosome-mediated paracrine miR-34a-5p［J］.EBioMedicine,2018,36:209-220.
［27］ SUN LP,XU K,CUI J,et al.Cancer-associated fibroblast-derived exosomal miR-382-5p promotes the migration and invasion of oral squamous cell carcinoma［J］.Oncol Rep,2019,42(4):1319-1328.
［28］ HE L,GUO J,FAN Z,et al.Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3［J］.Cell Signal,2023,106:110635.
［29］ LI L,LI C,WANG S,et al.Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype［J］.Cancer Res,2016,76(7):1770-1780.
［30］ YE B,DUAN Y,ZHOU M,et al.Hypoxic tumor-derived exosomal miR-21 induces cancer-associated fibroblast activation to promote head and neck squamous cell carcinoma metastasis［J］.Cell Signal,2023,108:110725.
［31］ LI W,HAN Y,ZHAO Z,et al.Oral mucosal mesenchymal stem cell-derived exosomes:A potential therapeutic target in oral premalignant lesions［J］.Int J Oncol,2019,54(5):1567-1578.
［32］ YU T,YU H,XIAO D,et al.Human bone marrow mesenchymal stem cell (hBMSCs)-derived miR-29a-3p-containing exosomes impede laryngocarcinoma cell malignant phenotypes by inhibiting PTEN［J］.Stem Cells Int,2022,2022:8133632.
［33］ HE L,PING F,FAN Z,et al.Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening［J］.Biomed Pharmacother,2020,121:109553.
［34］ SAKHA S,MURAMATSU T,UEDA K,et al.Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma［J］.Sci Rep,2016,6:38750.
［35］ LOU C,SHI J,XU Q.Exosomal miR-626 promotes the malignant behavior of oral cancer cells bytargeting NFIB［J］.Mol Biol Rep,2022,49(6):4829-4840.
［36］ LI CW,ZHENG J,DENG GQ,et al.Exosomal miR-106a-5p accelerates the progression of nasopharyngeal carcinoma through FBXW7-mediated TRIM24 degradation［J］.Cancer Sci,2022,113(5):1652-1668.
［37］ ZHAO Q,ZHENG X,GUO H,et al.Serum exosomal miR-941 as a promising oncogenic biomarker for laryngeal squamous cell carcinoma［J］.J Cancer,2020,11(18):5329-5344.
［38］ WANG J,ZHOU Y,LU J,et al.Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic andprognostic biomarkers for laryngeal squamous cell carcinoma［J］.Med Oncol,2014,31(9):148.
［39］ DAI D,TAN Y,GUO L,et al.Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroidcancer by small RNA sequencing［J］.Eur J Endocrinol,2020,182(1):111-121.
［40］ PAN Q,ZHAO J,LI M,et al.Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing［J］.Carcinogenesis,2020,41(1):18-24.
［41］ SAMSONOV R,BURDAKOV V,SHTAM T,et al.Plasma exosomal miR-21 and miR-181a differentiates follicular from papillarythyroid cancer［J］.Tumour Biol,2016,37(9):12011-12021.
［42］ TOMASETTI M,RE M,MONACO F,et al.miR-126 in intestinal-type sinonasal adenocarcinomas:exosomal transfer of miR-126 promotes anti-tumour responses［J］.BMC Cancer,2018,18(1):896.
［43］ CHEN W,LI G,LI Z,et al.Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymphnode metastasis in papillary thyroid carcinoma［J］.Endocrine,2022,75(3):846-855.
［44］ FAUR CI,ROMAN RC,JURJ A,et al.Salivary exosomal microRNA-486-5p and microRNA-10b-5p in oral and oropharyngeal squamous cell carcinoma［J］.Medicina (Kaunas),2022,58(10)：1478.
［45］ PATEL A,PATEL S,PATEL P,et al.Salivary exosomal miRNA-1307-5p predicts disease aggressiveness and poor prognosis in oral squamous cell carcinoma patients［J］.Int J Mol Sci,2022,23(18):10639.
［46］ WANG X,QIN X,YAN M,et al.Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression［J］.J Exp Clin Cancer Res,2019,38(1):151.
［47］ WANG J,LIU Y,ZHANG Y,et al.Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis［J］.Cancer Med,2023,12(11):12608-12621.
［48］ SAYYED AA,GONDALIYA P,MALI M,et al.miR-155 inhibitor-laden exosomes reverse resistance to cisplatin in a 3D tumor spheroid and xenograft model of oral cancer［J］.Mol Pharm,2021,18(8):3010-3025.
［49］ QIN X,GUO H,WANG X,et al.Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5［J］.Genome Biol,2019,20(1):12.
［50］ ZHENG Y,SONG A,ZHOU Y,et al.Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma［J］.J Cell Commun Signal,2020,14(4):389-402.
［51］ LU J,LIU QH,WANG F,et al.Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma［J］.J Exp Clin Cancer Res,2018,37(1):147.

Memo

Memo:
-
Last Update: 1900-01-01